thymopentin has been researched along with Immunologic Deficiency Syndromes in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (78.26) | 18.7374 |
1990's | 4 (17.39) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (4.35) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gong, T; Li, YZ; Liu, J; Sun, X; Zhang, ZR; Zuo, J | 1 |
Aiuti, F; Businco, L; Fiorilli, M; Galli, E; Goldstein, G; Quinti, I; Rossi, P; Seminara, R | 1 |
Joffe, MI; Pettifor, JM; Rabson, AR; Sochett, E | 1 |
Cooper, K; Hanifin, JM; Kang, K; Strannegård, IL; Strannegård, O | 1 |
Butler, M; Davies, EG; Levinsky, RJ; Linch, DC; Thomas, RM | 1 |
Aiuti, F; Businco, L; Seminara, R; Sirianni, MC | 1 |
Davies, EG; Goldstein, G; Levinsky, RJ | 1 |
Aiuti, F; Businco, L; Fiorilli, M; Galli, E; Goldstein, G; Le Moli, S; Quinti, I; Seminara, R | 1 |
Aiuti, F; Businco, L; DiGilio, G; Galli, E; Lulli, P; Paganelli, R; Rossi, P | 1 |
Abo, T; Aiuti, F; Cooper, MD; Quinti, I; Seminara, R; Sirianni, MC; Vierucci, A | 1 |
Martin-Du-Pan, RC | 1 |
Aiuti, F; Fiorilli, M; Goldstein, G; Pandolfi, F; Quinti, I; Sirianni, MC; Tosti, U | 1 |
Agarwal, SS; Biswas, S; Garg, SK; Haq, W; Mathur, KB; Singh, VK | 1 |
Doria, G; Frasca, D; Goso, C | 1 |
Altamura, M; Covelli, V; Decandia, P; Jirillo, E; Munno, I; Pellegrino, NM | 1 |
Afeltra, A; Amoroso, A; Di Rosa, R; Ferri, GM; Guidotti, G | 1 |
Hamilton, G; Meissl, G; Rath, T; Zöch, G | 1 |
Minakuchi, J; Okawa, H; Takagi, S; Yata, J | 1 |
Haneke, E | 1 |
Bolla, K; Faist, E; Riedel, A | 1 |
Auteri, A; D'Aniello, C; Di Perri, T; Falotico, N; Saletti, M | 1 |
Barcellini, W; Borghi, MO; De Bartolo, G; Doria, G; Frasca, D; Meroni, PL; Sguotti, C; Zanussi, C | 1 |
Alexander, JW; Gonce, S; Miskell, P; Waymack, JP | 1 |
4 review(s) available for thymopentin and Immunologic Deficiency Syndromes
Article | Year |
---|---|
Suppressor cell phenotype deficiency and its restoration by thymopoietin pentapeptide in atopic dermatitis.
Topics: Adult; Dermatitis, Atopic; Humans; Hypergammaglobulinemia; Immunoglobulin E; Immunologic Deficiency Syndromes; Leukocyte Count; Peptide Fragments; Phenotype; T-Lymphocytes; T-Lymphocytes, Regulatory; Thymopentin; Thymopoietins; Thymus Hormones | 1983 |
[Thymic hormones. Neuroendocrine interactions and clinical use in congenital and acquired immune deficiencies].
Topics: Acquired Immunodeficiency Syndrome; Autoimmune Diseases; Humans; Immunologic Deficiency Syndromes; Peptide Fragments; Thymalfasin; Thymic Factor, Circulating; Thymopentin; Thymopoietins; Thymosin; Thymus Extracts; Thymus Hormones | 1984 |
Thymopentin and splenopentin as immunomodulators. Current status.
Topics: Adjuvants, Immunologic; Animals; Autoimmune Diseases; Child; Dermatitis; Humans; Immunologic Deficiency Syndromes; Infections; Myasthenia Gravis; Neoplasms; Neuromuscular Agents; Peptide Fragments; Thymopentin; Thymopoietins | 1998 |
Thymopentin in dermatology.
Topics: Adjuvants, Immunologic; Humans; Immunologic Deficiency Syndromes; Opportunistic Infections; Peptide Fragments; Skin Diseases, Infectious; Thymopentin; Thymopoietins; Thymus Hormones | 1989 |
1 trial(s) available for thymopentin and Immunologic Deficiency Syndromes
Article | Year |
---|---|
Therapy with thymopoietin pentapeptide (TP-5) in 26 patients with primary immunodeficiencies.
Topics: Adolescent; B-Lymphocytes; Child; Child, Preschool; Clinical Trials as Topic; Female; Hormones; Humans; Immunity, Cellular; Immunologic Deficiency Syndromes; Infant; Male; Peptide Fragments; T-Lymphocytes; Thymopentin; Thymopoietins; Thymus Hormones; Time Factors | 1983 |
18 other study(ies) available for thymopentin and Immunologic Deficiency Syndromes
Article | Year |
---|---|
Inhalable microparticles as carriers for pulmonary delivery of thymopentin-loaded solid lipid nanoparticles.
Topics: Adjuvants, Immunologic; Administration, Inhalation; Animals; CD4-CD8 Ratio; Drug Carriers; Drug Stability; Immunologic Deficiency Syndromes; Lipids; Lung; Lymphocyte Subsets; Microscopy, Confocal; Nanoparticles; Rats; Rats, Wistar; Superoxide Dismutase; Surface Properties; Thymopentin | 2010 |
Thymopoietin pentapeptide treatment of primary immunodeficiencies.
Topics: Adolescent; Adult; Agammaglobulinemia; Ataxia Telangiectasia; Child; Child, Preschool; DiGeorge Syndrome; Female; Hormones; Humans; Immunity, Cellular; Immunoglobulin E; Immunologic Deficiency Syndromes; Infant; Male; Peptide Fragments; T-Lymphocytes; Thymopentin; Thymopoietins; Thymus Hormones | 1983 |
A case of Di George syndrome treated with thymopoietin pentapeptide (TP-5) demonstrating an adherent suppressor cell of lymphocyte function.
Topics: B-Lymphocytes; Cell Adhesion; DiGeorge Syndrome; Humans; Immunologic Deficiency Syndromes; Infant; Interleukin-2; Leukocyte Count; Lymphocyte Activation; Male; Peptide Fragments; Rosette Formation; T-Lymphocytes; T-Lymphocytes, Regulatory; Thymopentin; Thymopoietins; Thymus Hormones | 1982 |
Lymphocyte subpopulations in primary immunodeficiency disorders.
Topics: Agammaglobulinemia; B-Lymphocytes; Child; Child, Preschool; Female; Humans; Immunologic Deficiency Syndromes; Infant; Infant, Newborn; Leukocyte Count; Lymphocytes; Male; Peptide Fragments; Rosette Formation; T-Lymphocytes; Thymopentin; Thymopoietins | 1983 |
Severe combined immunodeficiencies, primary T-cell defects and DiGeorge syndrome in humans: characterization by monoclonal antibodies and natural killer cell activity.
Topics: Adolescent; Antibodies, Monoclonal; Child; Child, Preschool; Cytotoxicity, Immunologic; DiGeorge Syndrome; Female; Humans; Immunologic Deficiency Syndromes; Killer Cells, Natural; Male; Peptide Fragments; T-Lymphocytes; Thymopentin; Thymopoietins | 1983 |
Effect of synthetic thymic hormone (TP5) in children with T-cell immunodeficiencies.
Topics: Agammaglobulinemia; Child; Child, Preschool; Drug Evaluation; Female; Hormones; Humans; Immunologic Deficiency Syndromes; Infant; Male; Peptide Fragments; T-Lymphocytes; Thymopentin; Thymopoietins; Thymus Hormones; Time Factors | 1983 |
Bone marrow transplantation and thymopoietin pentapeptide treatment in two infants with immunodeficiency with predominant T-cell defects.
Topics: Antibodies, Monoclonal; Bone Marrow Transplantation; Female; HLA Antigens; Humans; Immunologic Deficiency Syndromes; Infant; Peptide Fragments; T-Lymphocytes; Thymopentin; Thymopoietins; Thymus Hormones; Time Factors | 1984 |
Usefulness of monoclonal antibodies in the diagnosis and monitoring of patients with primary immunodeficiencies: combined experience in three clinical immunology centers.
Topics: Agammaglobulinemia; Antibodies, Monoclonal; Ataxia Telangiectasia; B-Lymphocytes; Bone Marrow Transplantation; Chronic Disease; Female; Humans; Immunologic Deficiency Syndromes; Infant; Infectious Mononucleosis; Male; Peptide Fragments; Recurrence; Respiratory Tract Infections; T-Lymphocytes; Thymopentin; Thymopoietins; X Chromosome | 1983 |
Improvement of natural killer activity and of T cells after thymopoietin pentapeptide therapy in a patient with severe combined immunodeficiency.
Topics: Antigens; Hormones; Humans; Immunologic Deficiency Syndromes; Infant; Killer Cells, Natural; Leukocyte Count; Lymphocyte Activation; Male; Peptide Fragments; Receptors, Antigen, B-Cell; Rosette Formation; T-Lymphocytes; Thymopentin; Thymopoietins; Thymus Hormones | 1981 |
Effect of synthetic thymic humoral factor (THF-gamma 2) on T cell activities in immunodeficient ageing mice.
Topics: Aging; Amino Acid Sequence; Animals; Cells, Cultured; Female; Immunologic Deficiency Syndromes; Interleukin-2; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Molecular Sequence Data; Oligopeptides; T-Lymphocytes; T-Lymphocytes, Helper-Inducer; Thymalfasin; Thymopentin; Thymosin; Thymus Hormones | 1992 |
Administration of thymopentin to patients with phobic disorders improves depressed phagocytic functions.
Topics: Adult; Cytotoxicity, Immunologic; Female; Humans; Immunologic Deficiency Syndromes; In Vitro Techniques; Male; Middle Aged; Monocytes; Neutrophils; Phagocytes; Phagocytosis; Phobic Disorders; Thymopentin | 1990 |
[A clinico-epidemiological study on the efficacy of thymopentin therapy in patients with chronic bronchitis and cellular immunity deficiency].
Topics: Aged; Bronchitis; Chronic Disease; Drug Evaluation; Female; Humans; Immunity, Cellular; Immunologic Deficiency Syndromes; Killer Cells, Natural; Lung Diseases, Obstructive; Male; Middle Aged; Skin Tests; T-Lymphocytes; Thymopentin | 1990 |
Thymopentin (TP-5) in the treatment of the postburn and postoperative immunodeficiency syndrome.
Topics: Adjuvants, Immunologic; Adult; Burns; Humans; Immunologic Deficiency Syndromes; Leukocyte Count; Lymphocyte Activation; Middle Aged; Peptide Fragments; Phytohemagglutinins; Postoperative Complications; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory; Thymopentin; Thymopoietins; Thymus Hormones | 1989 |
Phenotypical and functional heterogeneity of the large granular lymphocytes increased after various treatments in a patient with combined immunodeficiency.
Topics: Adjuvants, Immunologic; Bone Marrow Transplantation; Humans; Immunologic Deficiency Syndromes; Infant; Killer Cells, Natural; Lymphocyte Activation; Male; Neutropenia; Peptide Fragments; Phenotype; Thymopentin; Thymopoietins; Thymus Gland; Thymus Hormones | 1989 |
Influence of thymopentin on postsurgical immune deficiency: a clinical pilot study.
Topics: Adjuvants, Immunologic; Aged; Cell Division; Humans; Immunologic Deficiency Syndromes; Middle Aged; Monocytes; Peptide Fragments; Postoperative Complications; Prospective Studies; Thymopentin; Thymopoietins; Thymus Hormones | 1987 |
[Model for acquired immunodeficiency caused by anesthesia and surgical procedures. Effect of treatment with thymopoietin pentapeptide (TP5)].
Topics: Adolescent; Adult; Anesthesia; Antibody Formation; Double-Blind Method; Drug Evaluation; Humans; Immunity, Cellular; Immunologic Deficiency Syndromes; Middle Aged; Models, Biological; Peptide Fragments; Postoperative Complications; Thymopentin; Thymopoietins; Thymus Hormones | 1986 |
In vivo immunopotentiating activity of thymopentin in aging humans: increase of IL-2 production.
Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aging; Antibodies, Monoclonal; Female; Humans; Immunologic Deficiency Syndromes; Interleukin-2; Lectins; Lymphocyte Activation; Lymphocytes; Male; Peptide Fragments; Stimulation, Chemical; Thymopentin; Thymopoietins; Thymus Hormones | 1987 |
Mechanisms of action of two new immunomodulators.
Topics: Adjuvants, Immunologic; Animals; Burns; Disease Models, Animal; Female; Guinea Pigs; Immunologic Deficiency Syndromes; Macrophages; Neutrophils; Opsonin Proteins; Peptide Fragments; Phagocytosis; Piperidines; Pseudomonas aeruginosa; Thymopentin; Thymopoietins; Thymus Hormones; Time Factors | 1985 |